Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 15th Congress of the European Hematology Association
Novel Agents Significantly Improve Outcomes in Multiple Myeloma
Barcelona, Spain / June 10-13, 2010
Barcelona - Novel agents, including a proteasome inhibitor and two immunomodulatory drugs, are changing the therapeutic landscape for multiple myeloma. Unlike in the past, the goal of treatment today is to attain complete remission....
PRIORITY PRESS - 36th Annual Meeting of the European Group for Blood and Bone Marrow Transplantation (EBMT)
New Antifungal Strategies in High-risk Stem Cell Transplant Recipients
Vienna, Austria / March 21-24, 2010
Vienna - Although Candida infection is still probably the most widespread fungal infection in a surgical setting, Aspergillus and other mold pathogens are a substantial cause of morbidity and mortality in immunosuppressed patients. In...
PRIORITY PRESS - 36th Annual Meeting of the European Group for Blood and Bone Marrow Transplantation (EBMT)
Progress in Infection Management of Allogeneic Stem Cell Recipients
Vienna, Austria / March 21-24, 2010
Vienna - In the last 10 years, widespread use of allogeneic hematopoietic stem cell transplantation has decreased the risk of recurrence in patients with aggressive hematological malignancies. However, the associated conditioning and...
PRIORITY PRESS - 51st Annual Meeting of the American Society of Hematology
Iron Overload Management: Potential for Improved Survival in Patients with MDS
New Orleans, Louisiana / December 5-8, 2009
New Orleans - A series of studies have underscored the importance of evaluating and treating iron overload in selected patients with myelodysplastic syndrome (MDS), including one that reinforces the likelihood of a survival advantage if...
PRIORITY PRESS - 51st Annual Meeting of the American Society of Hematology
Enhanced Directives for Anticoagulation in Cancer Patients
New Orleans, Louisiana / December 5-8, 2009
New Orleans - Prophylaxis for venous thromboembolism (VTE) has now been endorsed for hospitalized cancer patients without a bleeding contraindication by a broad array of influential medical organizations, including the American Society of...
PRIORITY PRESS - 51st Annual Meeting of the American Society of Hematology
New Strategies for Identifying Anti-FVIII Antibodies in Patients with Hemophilia
New Orleans, Louisiana / December 5-8, 2009
New Orleans - In patients with hemophilia, new and more sensitive strategies for identifying factor VIII (FVIII) antibodies may better characterize the immune response that often defeats recombinant FVIII therapies. The standard test has...
PRIORITY PRESS - 51st Annual Meeting of the American Society of Hematology
Optimizing Multiple Myeloma Induction and Maintenance Therapies in the Elderly
New Orleans, Louisiana / December 5-8, 2009
New Orleans - The standard of care for the treatment of multiple myeloma (MM) in elderly patients, who cannot usually tolerate high-dose therapy, was recently revised from a two-drug combination of melphalan and prednisone (MP) to a...
MEDICAL FRONTIERS - XXII Congress of the International Society on Thrombosis and Haemostasis
VTE Treatment and Prophylaxis: Strategies for Improved Intervention
Boston, Massachusetts / July 11-16, 2009
Boston - Thromboprophylaxis is considered a high priority safety intervention in hospitalized patients. In patients with cancer, the incidence and recurrence of venous thromboembolism (VTE) are more common. While several studies have...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the Toronto Myelodysplastic Syndromes Symposium: Progress and Challenges
Pathophysiology of Myelodysplastic Syndromes and Treatment Strategies to Change its Natural History
Toronto, Ontario / May 21-22, 2009
INTRODUCTION Treating patients with myelodysplastic syndromes (MDS) beyond supportive care has become a viable goal. As the pathobiology of MDS is unravelled, new therapies become available to treat these complex bone marrow failure...